Shield Therapeutics plc (FRA:1JS)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Feraccru	13.09M
Feraccru Growth	192.93%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	11.57M
United States Growth	302.57%
Netherlands	1.50M
Netherlands Growth	3.96%
South Korea	20.00K
South Korea Growth	300.00%